Compare Tunas Alfin Tbk. (TALF) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tunas Alfin Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Tunas Alfin Tbk. trades at Rp610 (market cap 825.6B, 27.7K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,610 (market cap 11.64T, 278.4K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 14.1× Tunas Alfin Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (278.4K versus 27.7K). Which is the better fit depends on your goals.
| TALF | TSPC | |
|---|---|---|
Market Cap | 825.6B | 11.64T |
Volume | 27.7K | 278.4K |
Lot | 277 | 2.78K |
Turnover | 16.69M | 723.93M |
Average Price | 602.67 | 2,600.31 |
Value | 16.69M | 723.93M |
Indicative Equilibrium Price | 610 | 2,610 |
Indicative Equilibrium Volume | 3 | 74 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tunas Alfin Tbk.
PT Tunas Alfin Tbk (the Company) was founded in 1977 and is based in Jakarta, Indonesia. With one of the largest production capacities, and some of the most advanced equipment and technologies in the region, the Company has also grown into one of the leading integrated fine and Fast Moving Consumer Goods (FMCG) packaging companies in Asia.The Company is currently capable of undertaking several coating processes such as Silicone, Hot Melt, Extrusion, Pressure/Self-Adhesive, Wax Coating and Anti-fungus Coating.
Read more on TALF →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
